Tidepool develops a diabetes data management application that offers glucose monitoring and automated insulin delivery solutions for patients.
$6M
Dec 14, 2018
-
ImmusanT develops therapeutic vaccines for the treatment of celiac disease.
-
Sep 10, 2018
-
SQZ is a Massachusetts-based biotechnology company that researches and develops cell therapies for the treatment of cancer and autoimmune diseases.
$72M
May 10, 2018
-
Semma Therapeutics is a biotechnology company that develops and commercializes stem cell-based therapies for the treatment of diabetes.
$113.9M
Nov 26, 2017
-
ViaCyte is a California-based regenerative medicine company that develops and commercializes cell replacement therapies for the treatment of diabetes.
$10M
May 21, 2017
-
